INS and type 2 diabetes mellitus: Their findings demonstrated that TBRP-1 markedly decreased blood glucose concentrations, glycated hemoglobin levels, and hepatic lipid content in T2DM mice, while enhancing insulin receptor substrate-1 and glucose transporter type 4 protein expression, consequently improving insulin sensitivity.